Although the effect of EE on Irak1 protein levels was not evaluated, our results shed light on the potential use of EE-based strategies to attenuate Irak1 expression as a novel non-pharmacological therapeutic option to modulate NF-κB signaling to reduce neuroinflammation in RTT patients. This evidence concerns the gene NFKB1 and Rett syndrome.